Be the first to like.

Share

The opioid manufacturer Insys Therapeutics agreed to pay $225 million to settle federal criminal and civil charges that it illegally marketed a highly addictive fentanyl painkiller to doctors, federal prosecutors said on Wednesday.

As part of the deal, a subsidiary of Insys will plead guilty to five counts of mail fraud and the company will pay a $2 million fine and $28 million in forfeiture, according to a statement from the United States attorney’s office in Massachusetts. The company will also pay $195 million to settle allegations that it violated the federal False Claims Act, which involves defrauding the federal government through drug sales to health care programs like Medicare.

A month ago, a federal jury in Boston found the company’s top executives, including the founder, John Kapoor, guilty of conspiring to fuel sales of the drug, Subsys, by bribing doctors and misleading insurance companies.

…continue reading ‘Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges’

Image via Flickr AttributionNo Derivative Works Some rights reserved by Senator McCaskill

Be the first to like.

Share
New York Times

Tags: , , , , , , , , , , , ,

Leave a Reply